Literature DB >> 731437

In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.

J I Székely, Z Dunai-Kovács, E Miglécz, A Z Rónai, S Bajusz.   

Abstract

The in vivo equivalent of pA2 values were determined in rat tail-flick and mouse hot-plate tests for naloxone against morphine, beta-endorphin and a synthetic enkephalin analog, (D-Met2,Pro5)-enkephalinamide, as analgesics. In mice the apparent pA2 value of naloxone against morphine (6.86) was similar to that found by previously and essentially the same values were obtained against the opioid peptides, indicating homogenous receptor population for the analgesics studied. In rats the pA2 of naloxone against morphine (7.17) was lower than against either beta-endorphin (7.55) or (D-Met2,Pro5)-enkephalinamide (7.51), warning that in rats such a homogeneity of the "analgesic" receptor population as was observed for mice may not exist.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731437

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.

Authors:  J Földes; A Váradi; A Gara; C Bános; P Vargha; K Török; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.

Authors:  J I Székely; E Miglécz; A Z Rónai
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human.

Authors:  J D Veldhuis; T J Worgul; R Monsaert; J M Hammond
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

4.  Species differences in the relative analgesic potencies of some classical opiates and opioid peptides.

Authors:  J I Székely; E Miglécz; S Bajusz
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

6.  Effect of propranolol treatment in pregnant rats on motor activity and avoidance learning of the offspring.

Authors:  Z Speiser; A Shved; S Gitter
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.